Optimizing the Efficacy of mRNA-based Cancer Vaccines to Generate Potent and Long-lasting CD8+ Responses
Time: 3:30 pm
day: Day One
Details:
- Learning from preclinical models to guide and optimize mRNA-based
vaccine platforms - Deciding the best combination therapy to use with mRNA
- Determining anti-tumor T cell efficacy and future directions
